Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy
NCT03168555 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2022-05-19
Summary
Investigate serial plasma samples of fibroblast growth factor 19 (FGF19) after oral stimulation with chenodeoxycholic acid in the same subjects before and after elective cholecystectomy
Conditions
- Bile Acid Malabsorption
- Cholelithiasis
Interventions
- DRUG
-
chenodeoxycholic acid
1250 mg CDCA is given with a study meal
Sponsors & Collaborators
-
Zealand University Hospital
lead OTHER
Principal Investigators
-
Christian Borup · Zealand University Hosipital
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-22
- Primary Completion
- 2019-05-15
- Completion
- 2019-05-15
Countries
- Denmark
Study Locations
More Related Trials
-
Study of Bile Acids in Patients With Peroxisomal Disorders
NCT00004442 ·Status: TERMINATED ·Phase: NA
-
Serum Metabolics-based Method for Diagnosing Bile Acid Diarrhoea
NCT06548009 ·Status: COMPLETED
-
Obeticholic Acid in Bile Acid Diarrhoea
NCT01585025 ·Status: COMPLETED ·Phase: PHASE2
-
Obeticholic Acid in Bariatric and Gallstone Disease
NCT01625026 ·Status: COMPLETED ·Phase: PHASE2
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Bile Acids As Determinants of Postprandial Metabolism
NCT06758453 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis
NCT01717599 ·Status: COMPLETED ·Phase: NA
-
A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
NCT03345589 ·Status: UNKNOWN ·Phase: PHASE4
-
Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans
NCT03201952 ·Status: TERMINATED ·Phase: PHASE1
-
Regulation of Sterol Homeostasis
NCT00018720 ·Status: COMPLETED
-
Regulation of Human Intestinal Bile Acid Transport in Health and Disease
NCT00018681 ·Status: COMPLETED
-
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374 ·Status: COMPLETED ·Phase: PHASE1
-
Gastric Emptying and Gallbladder Motility Study
NCT00940849 ·Status: COMPLETED ·Phase: NA
-
Effect of Bile Acids on the Secretion of Satiation Peptides in Humans
NCT01674946 ·Status: COMPLETED ·Phase: PHASE1
-
Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy
NCT01576458 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
NCT00004315 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
NCT00465751 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
NCT02420496 ·Status: WITHDRAWN ·Phase: PHASE2
-
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals
NCT06610695 ·Status: ENROLLING_BY_INVITATION
-
GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis
NCT01589523 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis
NCT01865812 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
NCT03253276 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
NCT02871882 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of Fatty Acid Composition of Triglycerides in Patients With Hypertriglyceridemia-induced Acute Pancreatitis
NCT04097990 ·Status: UNKNOWN ·Phase: NA
-
Cholic Acid for Hepatic Steatosis in Lipodystrophy
NCT00457639 ·Status: COMPLETED ·Phase: PHASE2